Is Viking Therapeutics Stock Going to $100? Key Signals
Viking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...
Index investing offers a straightforward path to retirement goals with broad market exposure and low costs. This intro explains why it often suits long-term planning and how to begin with simple steps.
21,933 articlesViking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
In 2025, Sophia Genetics is at a crossroads between expanding its software platform and tightening its financial disc...
The Roundhill Memory ETF DRAM has surged in 2026, roughly doubling and delivering a year-to-date gain near 100% as AI...
AI-driven analysis explores XRP's possible path to higher prices if Ripple secures a Fed master account. The piece ou...
Quantum stocks are on a rebound after a rough patch. This guide breaks down why ionq, rigetti, d-wave surging matters...
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Global defense markets are shifting as the US, Russia, and China advance missile programs. This report examines inves...
Palantir delivers a strong Q1, beating expectations with better profitability than many software peers, yet the stock...
XRP remains under scrutiny as 2026 unfolds, with faster settlement times and evolving regulation shaping its appeal. ...
A deep dive into mib: jean eric salata, chair of EQT, exploring how cross-cultural experience and AI-driven infrastru...
A senior executive walked away from a high-profile role with no plan and, within a day, laid the groundwork for a lea...